EVHEvolent Health, Inc.
$3.95-51% 1Y
$3.95
$2.1752 weeks$8.18
The financials
Evolent Health, Inc. by the numbers
Evolent Health, Inc. (EVH) reported revenue of $653M in Q2 2026 (quarter ended Jun 30, 2026), up 47% from the same quarter a year earlier. That came with a gross margin of 12% and net loss of $28M. For the full year FY2025, revenue was $1.88B (−27% year on year) and net income −$535M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $653M | $444M | +47% |
| Gross profit | $81M | $100M | −19% |
| Operating income | −$9.6M | −$1.2M | n/a |
| Net income | −$28M | −$20M | n/a |
| Diluted EPS | −$0.25 | −$0.44 | n/a |
Health Information Services
Ranks #19 of 20 by RyuScore